James R Anderson Selected Research

Rhabdomyosarcoma

11/2019	Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group.
1/2019	Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group.
1/2019	The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
1/2018	Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
9/2017	Patterns of chemotherapy-induced toxicities and outcome in children and adolescents with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
6/2017	Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
1/2016	Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
11/2014	Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
5/2014	Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group.
3/2014	Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: a report from the Children's Oncology Group.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James R Anderson Research Topics

Disease

30	Rhabdomyosarcoma 11/2019 - 06/2002
22	Neoplasms (Cancer) 01/2021 - 06/2002
10	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2002
10	Wilms Tumor (Wilm's Tumor) 10/2020 - 10/2009
4	Osteoarthritis 12/2021 - 01/2019
4	Sepsis (Septicemia) 01/2019 - 06/2007
4	Disease Progression 01/2019 - 09/2010
4	Embryonal Rhabdomyosarcoma 06/2017 - 04/2011
3	Anaplasia 01/2018 - 05/2011
3	Infections 11/2012 - 06/2007
3	Coronary Artery Disease (Coronary Atherosclerosis) 09/2005 - 12/2004
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
2	Retinal Degeneration 01/2019 - 07/2007
2	Neoplasm Metastasis (Metastasis) 01/2018 - 10/2012
2	Ganglion Cysts (Ganglion) 04/2013 - 07/2007
2	Cross Infection (Nosocomial Infection) 11/2012 - 01/2008
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2005 - 02/2003
1	Hypoxia (Hypoxemia) 09/2022
1	Rheumatoid Arthritis 03/2022
1	Polyps 01/2022
1	Cadaver (Cadavers) 12/2021
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021
1	Clear Cell Sarcoma 01/2019
1	Osteochondrosis (Osgood Schlatter Disease) 01/2019
1	Joint Diseases (Joint Disease) 01/2019
1	Sclerosis 11/2018
1	Residual Neoplasm 08/2015
1	Central Nervous System Diseases (CNS Diseases) 08/2015

Drug/Important Bio-Agent (IBA)

13	Vincristine (Oncovin)FDA LinkGeneric 10/2020 - 01/2008
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 09/2004
9	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2018 - 11/2009
8	Biomarkers (Surrogate Marker)IBA 03/2022 - 04/2013
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2006
6	Etoposide (VP 16)FDA LinkGeneric 10/2020 - 07/2006
5	Ifosfamide FDA LinkGeneric 01/2021 - 07/2006
4	Irinotecan (Camptosar)FDA LinkGeneric 10/2020 - 10/2010
3	Proteins (Proteins, Gene)FDA Link 03/2022 - 09/2010
3	Dobutamine FDA LinkGeneric 09/2005 - 12/2004
2	Blood Proteins (Serum Proteins)IBA 03/2022 - 09/2010
2	Peptides (Polypeptides)IBA 03/2022 - 01/2019
2	ProteomeIBA 03/2022 - 01/2019
2	Retinaldehyde (Retinal)IBA 01/2021 - 01/2019
2	pembrolizumabIBA 01/2020 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2019
2	Glutamic Acid (Glutamate)FDA Link 01/2018 - 07/2007
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2018 - 04/2013
2	Biological ProductsIBA 01/2017 - 03/2010
2	Rituximab (Mabthera)FDA Link 08/2015 - 11/2014
2	MyogeninIBA 05/2014 - 07/2013
1	Apolipoproteins MIBA 03/2022
1	Apolipoprotein C-IIIIBA 03/2022
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 03/2022
1	Liver X ReceptorsIBA 03/2022
1	Rheumatoid FactorIBA 03/2022
1	Anti-Citrullinated Protein AntibodiesIBA 03/2022
1	Selenoprotein PIBA 03/2022
1	Complement C4b-Binding ProteinIBA 03/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 03/2022
1	Lysine Carboxypeptidase (Carboxypeptidase N)IBA 03/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022
1	Oncogene Proteins (Oncogene Protein)IBA 03/2022
1	N-Acetylmuramoyl-L-alanine Amidase (Autolysin)IBA 03/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022
1	PolymersIBA 01/2022
1	PolyphosphatesIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 12/2021
1	AmmoniaIBA 12/2021
1	PutrescineIBA 12/2021
1	salicylhydroxamic acid (SHAM)IBA 12/2021
1	Carboplatin (JM8)FDA LinkGeneric 10/2020
1	temsirolimus FDA Link 11/2019
1	Bevacizumab (Avastin)FDA Link 11/2019
1	cixutumumabIBA 01/2019
1	Cytidine Monophosphate (CMP)IBA 01/2019
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2019
1	Insulin-Like Growth Factor Binding Protein 6IBA 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	epacadostatIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	LactoferrinIBA 01/2019
1	LigandsIBA 01/2019
1	Taurine FDA Link 11/2018
1	Phosphocreatine (Neoton)IBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	Pyruvic Acid (Pyruvate)IBA 01/2018
1	Citric Acid (Citrate)FDA LinkGeneric 01/2018
1	glycylproline (Gly-Pro)IBA 01/2018
1	Valine (L-Valine)FDA Link 01/2018
1	Alanine (L-Alanine)FDA Link 01/2018
1	Acetates (Acetic Acid Esters)FDA Link 01/2018
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2018
1	CreatinineIBA 01/2018

Therapy/Procedure

21	Therapeutics 10/2020 - 06/2002
16	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
15	Radiotherapy 01/2021 - 06/2002
6	Nephrectomy 01/2018 - 06/2010
2	Critical Care (Surgical Intensive Care) 11/2012 - 06/2007
2	Induction Chemotherapy 09/2010 - 11/2007
1	Euthanasia (Mercy Killing) 09/2022